Home » Research & Education » Research » Active Trials

Active Trials

 

  • Phase 1/2A, Multicenter, Randomized, Dose Escalation, Fellow-Eye Controlled, Study Evaluating the Safety and Clinical Response of a Single, Subretinal Administration of XXXXXX in Subjects with Visual Acuity Impairment Associated with Geographic Atrophy Secondary to Age-Related Macular Degeneration.
  • A Phase 2 Multicenter, Randomized, Double-Masked, Placebo-Controlled, Multi-Dose Study to Investigate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of XXXXXX in Subjects with Geographic Atrophy Secondary to Age-Related Macular Degeneration.